In this study, we report the anti-metastatic activity of AXT based on the suppression of invadopodia formation, EMT, consequent actin polymerization, matrix degradation, and the in vivo metastatic capacity of colon cancer cells. The gene discussed is CNTN2; the disease is malignant colon neoplasm.